Team:UCL/Background/Alzheimers

From 2013.igem.org

Revision as of 17:02, 14 August 2013 by 21Robin12 (Talk | contribs)

Over the last decade there has been mounting public interest in the emergence of genetic modification (GM) technologies, and a great deal of thought has been devoted to determining its risks, rewards, and overall impacts on society. These technologies promise a great deal, perhaps even treatments for brain diseases, such as Alzheimer's, where more conventional approaches have hit a dead end.Over the last decade there has been mounting public interest in the emergence of genetic modification (GM) technologies, and a great deal of thought has been devoted to determining its risks, rewards, and overall impacts on society. These technologies promise a great deal, perhaps even treatments for brain diseases, such as Alzheimer's, where more conventional approaches have hit a dead end.Over the last decade there has been mounting public interest in the emergence of genetic modification (GM) technologies, and a great deal of thought has been devoted to determining its risks, rewards, and overall impacts on society. These technologies promise a great deal, perhaps even treatments for brain diseases, such as Alzheimer's, where more conventional approaches have hit a dead end.